Showing results (91-100 of 350) with videos related to
Sort By:
Pageof 35
Best Practice & Research. Clinical Obstetrics & Gynaecology|February 11, 2012
Borderline ovarian tumoursClaes Göran Tropé, Janne Kaern, Ben DavidsonGynecologic Oncology|April 10, 2014
The clinical and diagnostic role of microRNAs in ovarian carcinomaBen Davidson, Claes G Tropé, Reuven ReichInternational Journal of Molecular Sciences|July 29, 2020
The Biological and Clinical Role of the Long Non-Coding RNA LOC642852 in Ovarian CarcinomaNatalie Filippov-Levy, Reuven Reich, Ben DavidsonAnticancer Research|December 8, 2020
The Biological Role of the Long Non-coding RNA LINK-A in Ovarian CarcinomaNatalie Filippov-Levy, Ben Davidson, Reuven ReichModern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2006
Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanomaKjersti Jørgensen, Ben Davidson, Viví Ann FlørenesVirchows Archiv : an International Journal of Pathology|December 15, 2023
Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometriumSonia Gatius, Xavier Matias Guiu, Ben DavidsonDiagnostic Cytopathology|July 12, 2002
Fine-needle aspiration cytology of lobular carcinoma in situMelek Ustün, Aasmund Berner, Ben Davidson, et al.Cytopathology : Official Journal of the British Society for Clinical Cytology|December 7, 2019
MGMT promoter methylation is a rare epigenetic change in malignant effusionsMarta Brunetti, Ioannis Panagopoulos, Francesca Micci, et al.Current Opinion in Oncology|August 18, 2004
Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literatureEdwin M Posadas, Ben Davidson, Elise C KohnHuman Pathology|July 29, 2008
Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinomaBen Davidson, Ie-Ming Shih, Tian-Li WangPageof 35